Institute for OneWorld Health

In Vitro Diagnostics Acquisitions /In Vitro Diagnostics Cepheid Novartis AG Novartis AG has licensed exclusive rights to Cepheid 's (DNA analysis) Xpert BCR-ABL assay, which monitors the BCR-

The so-called "neglected diseases" affect some of the world's poorest people. In many cases, the cost of controlling these diseases is tiny in comparison with the benefits their eradication would brin

RXi Pharmaceuticals, a US biopharmaceutical company focused on the development and commercialisation of therapeutics based on RNAi, has appointed Dr Richard Chin, chief executive officer of the Instit

The Institute for OneWorld Health, a US non-profit pharmaceutical company developing drugs for neglected infectious diseases in the developing world, has appointed Dr Menghis Bairu to its board of dir